Choose your lawyers or partners according to the appropriate search criteria:

Practice Areas

Peter Klappich

Attorney (Rechtsanwalt)
Practice Areas:

Litigation and Arbitration


German, English

Office Cologne

Telephone: +49 221 2091 653
Telefax: +49 221 2091 333



Peter Klappich specialises in advising and litigating on behalf of national and multinational pharmaceutical companies in a wide range of regulatory, competition and commercial issues. He has been involved in many major product liability cases in Germany and other European jurisdictions, including cases concerning consumer products, pharmaceuticals, chemicals, automobiles, mechanical devices and other equipment. He regularly acts for insurants and insurers in product liability policy cases and advises on product liability policy coverage reviews. In addition, he deals with product safety issues including product liability risk prevention, product recalls and the management of litigation risks.

The US-American publishing company Best Lawyers voted him to be one of the best lawyers in Germany for Litigation and Pharmaceuticals Law.


Career / Education

Peter is a partner of Oppenhoff & Partner. He was a partner at Oppenhoff & Rädler / Linklaters LLP from 1982 to 2007. He studied law at the Universities of Heidelberg and Cologne.


Books and Legal Commentaries

Pharma Recht, 2010, "Anmerkung zum Urteil des BGH vom 12.5.2010 – I ZR 185/07 – One Touch Ultra" [Annotation of the decision of the Federal Court of Justice dated 12 May 2010 – I ZR 185/07 – One Touch Ultra] p. 488

"Konformitätsbewertungsverfahren für umgepackte Parallelim-porte von In-vitro-Diagnostika zur Eigenanwendung" [Conformity assessment procedures for repackaged parallel imports of in-vitro diagnostic medical devices for self-testing] (in collaboration with Ulrich Juknat and Julia Schelcher née Klages)

Pharma Recht, 2009, "Anmerkung zum Urteil des OLG Hamburg vom 30.6.2009 – 3 U 13/09" – [Annotation of the decision of the Higher Regional Court of Hamburg dated 30 June 2009 – 3 U 13/09], p. 526

"Unzulässigkeit der Werbung für Arzneimittel mit Testurteilen" [The impermissibility of using test results to promote pharmaceuticals] (in collaboration with Julia Schelcher née Klages)